HUMASIS CO., LTD. Logo

HUMASIS CO., LTD.

Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.

205470 | KO

Overview

Corporate Details

ISIN(s):
KR7205470008
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 전파로 88 신원비젼타워 114호.502호.504호.604호.604-1호.비03-1호.비03-2호, 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

HUMASIS CO., LTD. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) medical devices. Since its establishment in 2000, the firm has concentrated on Point-of-Care Testing (POCT) solutions, delivering rapid and accurate diagnostic results. Its product portfolio includes a wide range of immunodiagnostic rapid test kits for the early screening of conditions such as infectious diseases, cardiac markers, and tumor markers. A key aspect of its strategy is the in-house development and production of core bio-materials, such as diagnostic antigens, to ensure the quality and accuracy of its kits. The company also provides compact diagnostic instruments for quantitative analysis. Humasis serves a global market, exporting its products to numerous countries with the goal of empowering individuals through accessible self-health management tools.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Legal Proceedings Report
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구) (손해배상청구 등)
Korean 21.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-07-28 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구) (손해배상청구 등 항소)
Korean 14.6 KB
2025-07-25 00:00
Legal Proceedings Report
기타경영사항(자율공시)
Korean 7.3 KB
2025-07-07 00:00
Legal Proceedings Report
소송등의판결ㆍ결정(일정금액이상의청구)
Korean 12.9 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.4 KB
2025-03-18 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 194.6 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 636.0 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 187.5 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.3 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 193.8 KB
2025-03-06 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 193.1 KB
2025-02-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.2 KB

Automate Your Workflow. Get a real-time feed of all HUMASIS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HUMASIS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HUMASIS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.